Timothy D. Henry et al.: The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis. In: Circulation. Nr.107, 2003, S.1359–1365 (ahajournals.org).
ajkd.org
Hassane Izzedine et al.: Angiogenesis Inhibitor Therapies: Focus on Kidney Toxicity and Hypertension. In: American Journal of Kidney Diseases. Nr.50, 2007, S.203–218 (ajkd.org).
Xiaolei Zhu et al.: Risks of Proteinuria and Hypertension With Bevacizumab, an Antibody Against Vascular Endothelial Growth Factor: Systematic Review and Meta-Analysis. In: American Journal of Kidney Diseases. Nr.49, 2007, S.186–193 (ajkd.org).
doi.org
S. Cebe Suarez, M. Pieren u. a.: A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2. In: Cellular and Molecular Life Sciences. 63, 2006, S. 2067–2077, doi:10.1007/s00018-006-6254-9.
K. M. Mohamed, A. Le u. a.: Correlation between VEGF and HIF-1alpha expression in human oral squamous cell carcinoma. In: Experimental and molecular pathology, Band 76, Nummer 2, April 2004, S. 143–152, doi:10.1016/j.yexmp.2003.10.005, PMID 15010293.
D. Shweiki, A. Itin u. a.: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. In: Nature Band 359, Nummer 6398, Oktober 1992, S. 843–845, doi:10.1038/359843a0, PMID 1279431.
S Yla-Herttuala, TT Rissanen, I Vajanto, J Hartikainen: Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. In: J Am Coll Cardiol., 2007 Mar 13, 49(10), S. 1015–1026, PMID 17349880.
K. M. Mohamed, A. Le u. a.: Correlation between VEGF and HIF-1alpha expression in human oral squamous cell carcinoma. In: Experimental and molecular pathology, Band 76, Nummer 2, April 2004, S. 143–152, doi:10.1016/j.yexmp.2003.10.005, PMID 15010293.
D. Shweiki, A. Itin u. a.: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. In: Nature Band 359, Nummer 6398, Oktober 1992, S. 843–845, doi:10.1038/359843a0, PMID 1279431.